Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs

Drug Testing and Analysis

Volumn 8, Issue 9, 2016, Pages 910-919

  Westphal, Folker ^a   Girreser, Ulrich ^b   Waldmüller, Delia ^c  

^a State Bureau of Criminal Investigation Schleswig Holstein   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Laboratory Berlin   (Germany)

Author keywords

3,4 DMA NBOMe; 4 EA NBOMe; 4 MMA NBOMe; 5 APB NBOMe; designer drug; GC MS; IR; NMR

Indexed keywords

COPYRIGHTS; DRUG PRODUCTS; MASS SPECTROMETRY;

3,4-DMA-NBOME; 4-EA-NBOME; 4-MMA-NBOME; 5-APB-NBOME; ANALYTICAL CHARACTERIZATION; DESIGNER DRUGS; DIMETHOXYAMPHETAMINE; GC-MASS SPECTROMETRIC; PARTIAL STRUCTURES; PURE COMPOUNDS;

NUCLEAR MAGNETIC RESONANCE;

3,4-DIMETHOXYAMPHETAMINE; 4' METHYLMETHCATHINONE; 5-(2-AMINOPROPYL)BENZOFURAN; AMPHETAMINE DERIVATIVE; BENZOFURAN DERIVATIVE; CENTRAL STIMULANT AGENT; DESIGNER DRUG; METHAMPHETAMINE; N ETHYLAMPHETAMINE; PHENETHYLAMINE DERIVATIVE; PROPYLAMINE; SEROTONIN 2 AGONIST;

ANALOGS AND DERIVATIVES; CHEMISTRY; INFRARED SPECTROSCOPY; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUBSTANCE ABUSE;

AMPHETAMINES; BENZOFURANS; CENTRAL NERVOUS SYSTEM STIMULANTS; DESIGNER DRUGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAGNETIC RESONANCE SPECTROSCOPY; METHAMPHETAMINE; PHENETHYLAMINES; PROPYLAMINES; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUBSTANCE ABUSE DETECTION;

EID: 85028247704     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1889     Document Type: Article

References (25)

1. D. Zuba, K. Sekula. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs. Drug Test. Anal. 2013, 5, 634.
2. D. Zuba, K. Sekula. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G) – a new designer drug. Drug Test. Anal. 2013, 5, 549.
3. D. Zuba, K. Sekula, A. Buczek. Identification and characterization of 2,5-dimethoxy-4-nitro-β-phenethylamine (2C-N) – a new member of 2C-series of designer drug. Forensic Sci. Int. 2012, 222, 298.
4. D. Zuba, K. Sekula, A. Buczek. 25C-NBOMe – New potent hallucinogenic substance identified on the drug market. Forensic Sci. Int. 2013, 227, 7.
5. J. L. Poklis, J. Charles, C. E. Wolf, A. Poklis. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomed. Chromatogr. 2013, 27, 1794.
6. EMCDDA. Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) in the framework of the Council Decision on new psychoactive substances. 2014. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_228239_EN_25I-NBOMe_RAR_with_annexes.pdf, last accessed on September 2015
7. J. L. Poklis, D. J. Clay, A. Poklis. High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens. J. Anal. Toxicol. 2014, 38, 113.
8. J. L. Poklis, C. R. Nanco, M. M. Troendle, C. E. Wolf, A. Poklis. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test. Anal. 2014, 6, 764.
9. S. L. Hill, T. Doris, S. Grung, S. Katebe, A. Lomas, M. Dunn, P. Blain, S. H. L. Thomas. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin. Toxicol. 2013, 51, 487.
10. M. H. Tang, C. K. Ching, M. S. Tsui, F. K. Chu, T. W. Mak. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clin. Toxicol. 2014, 52, 561.
11. S. D. Brandt, S. P. Elliott, P. V. Kavanagh, N. M. Dempster, M. R. Meyer, H. H. Maurer, D. E. Nichols. Analytical characterization of bioactive N-benzyl substituted phenethylamines and 5-methoxytryptamines. Rapid Commun. Mass Spectr. 2015, 29, 573.
12. D. E. Nichols, M. F. Sassano, A. L. Halberstadt, L. M. Klein, S. D. Brandt, S. P. Elliott, W. Fiedler. N-Benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with a series of phenethylamine analogues. ACS Chem. Neurosci. 2015, 6, 1165.
13. 2A/2C Agonists. ACS Chem. Neurosci. 2014, 5, 243.
14. 2A/2C partial agonists. Bioorg. Med. Chem. 2015, 23, 3933.
15. J. Llinearés, J. Elguero, R. Faure, E.-J. Vincent. Carbon-13 NMR studies of nitrogen compounds. I – Substituent effects of amino, acetamido, diacetamido, ammonium and trimethylammonium groups. Org. Magn. Res. 1980, 14, 20.
16. T. D. Nixon, M. K. Whittlesey, J. M. J. Williams. Ruthenium-catalysed transfer hydrogenation reactions with dimethylamine borane. Tetrahedron Lett. 2011, 52, 6652.
17. S. Bradamante, G. A. Pagini. Substituent effect treatment of interactions betweeen contiguous functionalities G-X. Remote response to polar and inductive influence of X on G = C(sp3) and –N. J. Org. Chem. 1980, 45, 105.
18. C. Bornschein, S. Werkmeister, K. Junge, M. Beller. TBAF-catalyzed hydrosilylation for the reduction of aromatic nitriles. New. J. Chem. 2013, 37, 2061.
19. A. Stanczuk, N. Morris, E. A. Gardner, P. Kavanagh. Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in internet purchased products. Drug Test. Anal. 2013, 5, 270.
20. E. Pretsch, P. Bühlmann, M. Badertscher. Structure Determination of Organic Compounds: Tables of Spectral Data, 4th Edn Springer, Berlin, 2010.
21. R. Heim. Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur (Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure). PhD thesis, Free University, Berlin, 2003.
22. M. R. Braden. Towards a biophysical understanding of hallucinogen action. PhD thesis, Purdue University, West Lafayette, IN, USA, 2007.
23. M. R. Braden, J. C. Parrish, J. C. Naylor, D. E. Nichols. Molecular interaction of serotonin 5-HT2A receptor residues phe339(6.51) and phe340(6.52) with superpotent-benzyl phenethylamine agonists. Mol. Pharmacol. 2006, 70, 1956.
24. M. E. Silva, R. Heim, A. Strasser, S. Elz, S. Dove. Theoretical studies on the interaction of partial agonists with the 5HT2A receptor. J. Comput. Aided Mol. Des. 2011, 25, 51.
25. A. Shulgin, A. Shulgin. PIHKAL: A Chemical Love Story, Berkeley, CA, Transform Press, 1991.